Kirsty M. Sharplin

Port Road
Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm.

Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm.

Journal: Leukemia research

Published: November 01, 2024

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Journal: Nature communications

Published: May 31, 2024

Scoping Review of Factors Associated with Stem Cell Mobilization and Collection in Allogeneic Stem Cell Donors.

Scoping Review of Factors Associated with Stem Cell Mobilization and Collection in Allogeneic Stem Cell Donors.

Journal: Transplantation and cellular therapy

Published: March 07, 2024

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

Journal: Cancers

Published: May 27, 2023

CAR T in patients with large B-cell lymphoma not fit for autologous transplant.

CAR T in patients with large B-cell lymphoma not fit for autologous transplant.

Journal: British journal of haematology

Published: January 11, 2023

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Journal: Blood

Published: September 06, 2022

A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.

A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.

Journal: British journal of haematology

Published: January 25, 2022

The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL).

The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL).

Journal: Leukemia & lymphoma

Published: January 07, 2022

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Journal: British journal of haematology

Published: July 29, 2021

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.

Journal: Blood advances

Published: June 07, 2021

Outcomes and health care utilization of older patients with acute myeloid leukemia.

Outcomes and health care utilization of older patients with acute myeloid leukemia.

Journal: Journal of geriatric oncology

Published: December 24, 2019

Chronic myeloid leukaemia: The dangers of not knowing your BCR-ABL1 transcript.

Chronic myeloid leukaemia: The dangers of not knowing your BCR-ABL1 transcript.

Journal: Leukemia research

Published: September 24, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026